ICO ATLANTICO NETWORK - Get profit from medical services
The market of pharmaceutical products and medical services is one of the largest and most profitable markets in the world. However, there are certain problems in the work of this market, which have a negative impact not only on ordinary citizens, but also on insurance companies. Such problems include:
- unsatisfactory quality of services provided by employees of medical institutions;
- the inability of patients to choose a specialist or a medical institution;
- presence on the market of low-quality drugs or their fakes;
- overestimation of the cost of medical services and prices for popular medicines;
- falsification of insurance claims by doctors for the purpose of receiving payments.
To solve all above problems and improve the quality of services provided by doctors and medical institutions, will allow a new project called ATLANTICO Network.
Project objective
The main goal of the developers of the ATLANTICO Network is to create a tool for the interaction of all participants in the market of pharmaceutical products and medical services. In addition, this project aims to ensure transparent relations between patients, doctors, insurance companies and pharmaceutical companies in order to minimize risks and improve the quality of medical services.
Principle of operation
This platform has 6 built-in modules that provide interaction between participants and the Blockchain platform. All these 6 modules are divided into 3 levels, which include:
- quality assessment;
- the level of services and products that allows you to add new products and services to the platform;
- the member level, which allows you to add other members to the network to interact with them.
The main participants of this network are:
- patients and consumers;
- insurance organization;
- doctors;
- medical institution;
- pharmacies;
- pharmaceutical company
So, let's take a closer look at each module. The first one is the module of evaluation of the quality of the products, allowing to leave comments and of a product of the pharmaceutical company and put her assessment. It is worth noting that the assessment will be able to put not only consumers but also physicians and medical institutions.
The second module allows to assess the quality of services provided. Comments in this section can be left entirely to the patients.
The third module is intended for pharmaceutical companies engaged in the production of drugs. It allows you to enter new drugs into the system and add information about them. Other members can only view the relevant data.
The fourth module allows you to add services and information about them. Only doctors and medical institutions can make changes in the fourth module.
The fifth module is a personal account in which each of the participants of the system must provide complete information about themselves or about their company.
The sixth module is a bonus accumulation system that allows the platform participants to receive a reward for their ratings and written comments on a product or service.
It is important to note that the platform uses Blockchain technology to ensure the integrity of ratings and comments, as well as transparency.
The main currency of this platform will be ATL tokens that allow participants to interact with each other. It will be possible to buy these coins during the ICO, as well as after its completion on the crypto-currency exchanges.
Dates and details of the ICO
The developers plan to sell 250 million coins. The sale will be carried out in the period from August 1 to October 31 of the current year. The cost of 1 ATL will be 0.0001 ETH.
Softcap project - $ 3 million, hardcap - $ 15 million.
The distribution of funds is as follows:
Conclusion
This project will allow to avoid fraudulent actions on the part of doctors and medical institutions, to exclude the possibility of counterfeit medicines on the market and will significantly improve the quality of medical services. In this regard, the probability of success ATLANTICO Network is very large.
Special attention should be paid to the fact that this project began its development not in the current year, but in 1987 with the company Atlantic International Finance. Therefore, we can safely say that the project is not a Scam.
Also, special attention should be paid to the profits that developers promise investors. The figures presented are quite real. In the first year, the volume of profit will be 1 cent per 1 ATL coin. However, in 2022, the income of investors will increase to 344 dollars per year by 1 ATL token.
Pay attention to this project, while there is still a possibility.
Official resources of the project ATLANTICO Network:
WEBSITE: https://www.atlantico-network.io
TELEGRAM: https://t.me/AtlantICO_network
WHITEPAPER: https://www.atlantico-network.io/assets/doc/whitepaper-en.pdf
ANN THREAD: https://bitcointalk.org/index.php?topic=4720272.0
FACEBOOK: https://www.facebook.com/atlanticonetwork/
TWITTER: https://twitter.com/AtlantICOnetwo1
VK: https://vk.com/atlanticonetwork
MEDIUM: https://medium.com/@AtlantICOnetwo1
REDDIT: https://new.reddit.com/user/atlantico_network
YOUTUBE: https://www.youtube.com/channel/UCUBbNyF-BUX3oGj3ZnqynLg
GITHUB: https://www.youtube.com/channel/UCUBbNyF-BUX3oGj3ZnqynLg
AUTHORSHIP:
MY BITCOINTALK USERNAME: klimenok1991
MY BITCOINTALK PROFILE LINK: https://bitcointalk.org/index.php?action=profile;u=1238493
MY NEM ADDRESS: NB3FCY-64W2HP-VM6FQ6-VAJZ5D-DH6NR2-MFKQN5-YBG3
UNIQUENESS 100%: https://text.ru/antiplagiat/5bd97e033d72d
very informative ways to remove communication gap between patients and doctors... its a very good project ..
The leaders of this project have a huge experience in doing business of this kind and Atlantico, will certainly be a success
The medical and pharmaceutical industry is growing and profitable, but has a huge number of problems. I hope that the Atlantico platform will bring order to this sector
Cool project! And one of the key advantages is that Atlantico participates in all sorts of crypto, blockchain forums, and also enter into serious contracts
Promising and interesting project, and most importantly a useful product. The project has development potential. Thank you for the review, take a closer look at the project!
The project has quite an experienced and multinational team, I hope this will help in scaling the platform